Cancer News and Research

Latest Cancer News and Research

High-fiber diets may control progression of prostate cancer

A high-fiber diet may have the clinical potential to control the progression of prostate cancer in patients diagnosed in early stages of the disease.

10 Jan 2013

Simple education program increases doctor's ADR rate and reduces risk of colorectal cancer

Most people know a colonoscopy requires some preparation by the patient. Now, a Mayo Clinic physician suggests an additional step to lower the risk of colorectal cancer: Ask for your doctor's success rate detecting easy-to-miss polyps called adenomas.

9 Jan 2013

Surgical methods outperform radiation therapy in prostate cancer

A surgical method for treating localized prostate cancer may be a better option for patients than radiation therapy, show findings from a cost-effectiveness analysis.

9 Jan 2013

Oxaliplatin and bevacizumab disappoint for rectal cancer

The addition of bevacizumab and oxaliplatin to standard neoadjuvant chemoradiotherapy does not enhance clinical response rates in rectal cancer, show phase II study results.

9 Jan 2013

VolitionRx to commence large internal clinical study for Nucleosomics diagnostic products

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests, announces that it will commence a large internal clinical study for its Nucleosomics diagnostic products this month.

9 Jan 2013

Moffitt Cancer Center initiates PV-10 Phase 1 study in melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, reports that the Moffitt Cancer Center has initiated a Phase 1 study to investigate potential immune biomarkers in both tumor tissue and peripheral blood after intralesional PV-10 injection of melanoma tumors.

9 Jan 2013

Kingston University professor receives prestigious prize for work on drug metabolism

The Dean of the Faculty of Science, Engineering and Computing at London's Kingston University has received a prestigious prize recognising her lifetime's work on drug metabolism.

9 Jan 2013

Overall cancer death rates continue to decline in the U.S.: Report

The Annual Report to the Nation on the Status of Cancer, 1975-2009, shows that overall cancer death rates continued to decline in the United States among both men and women, among all major racial and ethnic groups, and for all of the most common cancer sites, including lung, colon and rectum, female breast, and prostate.

9 Jan 2013

CTI initiates enrollment in pacritinib Phase 3 trial for myelofibrosis

Cell Therapeutics, Inc. (CTI) today announced that the Company has initiated clinical trial sites and began enrolling patients in a Phase 3 clinical trial, known as PERSIST-1 or PAC325, for pacritinib, CTI's investigational JAK2 inhibitor, which is being evaluated for the treatment of patients with myelofibrosis.

9 Jan 2013

New scoring system can help clinicians better identify non-ICU patients at risk for GI bleeding

Critically ill patients in hospital intensive care units (ICUs) are routinely prescribed acid-suppressive medications to reduce their risk of developing stress ulcers and gastrointestinal bleeding, both of which can result from being in a stressful environment and from being intubated. Over the years, this routine practice has often been extended to patients outside the ICU, despite a lack of evidence that this population is at significant risk of these complications.

9 Jan 2013

Combination of pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer

A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer (ATC), according to a Mayo Clinic-led study published in the journal Science Translational Medicine.

9 Jan 2013

Key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis

Researchers at Yale School of Medicine have identified a key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis. The study, which paves the way for developing novel targeted ovarian cancer therapies, is published online in the current issue of Cell Cycle.

9 Jan 2013

Tunisian women more likely to suffer from obesity than male compatriots

Men and women in Tunisia are not equal before the scales. Tunisian women are three times as likely to suffer from obesity as their male compatriots.

9 Jan 2013

Scientists define structure of α-catenin protein

Scientists know that cells in all higher organisms cells need to bind to each other for the development, architecture, maintenance and function of tissues. Mysteries have remained, however, about exactly how cells manage this feat.

9 Jan 2013

ISCT selects Elsevier to publish Cytotherapy

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce that the International Society for Cellular Therapy (ISCT) has selected Elsevier to publish Cytotherapy: The Journal of Cell Therapy effective January 2013.

8 Jan 2013

Adolescents may lose hepatitis B virus protection despite vaccination as infants

New research reveals that a significant number of adolescents lose their protection from hepatitis B virus (HBV) infection, despite having received a complete vaccination series as infants. Results in the January 2013 issue of Hepatology, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases, suggest teens with high-risk mothers (those positive for HBeAg) and teens whose immune system fails to remember a previous viral exposure (immunological memory) are behind HBV reinfection.

8 Jan 2013

Genomic and cellular solutions to be featured by Beckman Coulter Life Sciences at SLAS2013

Bringing together genomic and cellular sample preparation with integrated solutions to highlight their Automation with a Human Touch theme.

From Beckman Coulter Life Sciences - Automation and Genomics 8 Jan 2013

FDA approves use of iCAD's PowerLook AMP with Philips MicroDose Digital Mammography System

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced approval by the U.S. Food and Drug Administration for use of the company's next generation mammography computer-aided detection platform, PowerLook Advanced Mammography Platform, with Digital CAD for Philips' MicroDose Full-Field Digital Mammography System.

8 Jan 2013

Spectrum Pharmaceuticals reveals positive RenaZorb Phase 1 clinical trial results

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced positive, statistically significant data from the Company's Phase 1 clinical trial evaluating the safety and tolerability of RenaZorb (also referred to as SPI-014) in healthy volunteers.

8 Jan 2013

Seven scientists named 2013 recipients of Damon Runyon-Rachleff Innovation Award

The Damon Runyon Cancer Research Foundation announced that seven scientists with novel approaches to fighting cancer have been named 2013 recipients of the Damon Runyon-Rachleff Innovation Award.

8 Jan 2013

Cancer News and Research

Latest Cancer News and Research

High-fiber diets may control progression of prostate cancer

Simple education program increases doctor's ADR rate and reduces risk of colorectal cancer

Surgical methods outperform radiation therapy in prostate cancer

Oxaliplatin and bevacizumab disappoint for rectal cancer

VolitionRx to commence large internal clinical study for Nucleosomics diagnostic products

Moffitt Cancer Center initiates PV-10 Phase 1 study in melanoma

Kingston University professor receives prestigious prize for work on drug metabolism

Overall cancer death rates continue to decline in the U.S.: Report

CTI initiates enrollment in pacritinib Phase 3 trial for myelofibrosis

New scoring system can help clinicians better identify non-ICU patients at risk for GI bleeding

Combination of pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer

Key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis

Tunisian women more likely to suffer from obesity than male compatriots

Scientists define structure of α-catenin protein

ISCT selects Elsevier to publish Cytotherapy

Adolescents may lose hepatitis B virus protection despite vaccination as infants

Genomic and cellular solutions to be featured by Beckman Coulter Life Sciences at SLAS2013

FDA approves use of iCAD's PowerLook AMP with Philips MicroDose Digital Mammography System

Spectrum Pharmaceuticals reveals positive RenaZorb Phase 1 clinical trial results

Seven scientists named 2013 recipients of Damon Runyon-Rachleff Innovation Award

Cancer Research - Second Edition eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Newsletters you may be interested in